Synthesis and antimicrobial activities of halogenated bis(hydroxyphenyl)methanes. 2009

Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Republic of Korea.

A series of halophenols was prepared by the reaction of bis(hydroxyphenyl)methanes with effective halogenating agents such as bromine and sulfuryl chloride. One of these compounds, a biologically active halophenol--2,2',3,3'-tetrabromo-4,4',5,5'-tetrahydroxydiphenylmethane (1)--frequently isolated from red algae, was synthesized for the first time. Other halophenols included several novel compounds, together with known derivatives that were synthesized from the phenolic intermediates, bis(3,4-dihydroxyphenyl)methane (5) and bis(2-hydroxyphenyl)methane (14). All of the synthesized compounds were tested for antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. The preliminary structure-activity relationship was investigated in order to determine the essential structural requirements for their antimicrobial activity. Of all these halophenols, 2,2',3,3',6-pentabromo-4,4',5,5'-tetrahydroxydiphenylmethane (8) was found to be the most active against Candidaalbicans, Aspergillusfumigatus, Trichophytonrubrum, and Trichophytonmentagrophytes while 3,3',5,5'-tetrachloro-2,2'-dihydroxydiphenylmethane (18) exerted a powerful antibacterial effect against Staphylococcusaureus, Bacillussubtilis, Micrococcusluteus, Proteusvulgaris, and Salmonellatyphimurium.

UI MeSH Term Description Entries
D008697 Methane The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D002733 Chlorophenols Phenols substituted with one or more chlorine atoms in any position. Chlorophenol,Hydroxychlorobenzenes
D006219 Halogens A family of nonmetallic, generally electronegative, elements that form group 17 (formerly group VIIa) of the periodic table. Halogen,Group 17 Elements,Elements, Group 17
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
April 2009, Journal of enzyme inhibition and medicinal chemistry,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
December 2010, Bioorganic & medicinal chemistry letters,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
August 1999, Bioorganic & medicinal chemistry letters,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
November 2015, Bioorganic & medicinal chemistry,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
November 1994, Biochemical Society transactions,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
November 1980, Federation proceedings,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
June 2015, Letters in organic chemistry,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
April 2015, Steroids,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
December 2018, ACS medicinal chemistry letters,
Ki-Bong Oh, and Ji Hye Lee, and Jong Wook Lee, and Kyung-Mi Yoon, and Soon-Chun Chung, and Heung Bae Jeon, and Jongheon Shin, and Hyi-Seung Lee
January 1977, Journal of environmental pathology and toxicology,
Copied contents to your clipboard!